Literature DB >> 15289742

Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations.

J Puel1, P Valensi, G Vanzetto, V Lassmann-Vague, J-L Monin, Ph Moulin, Ch Ziccarelli, H Mayaudon, M Ovize, S Bernard, E Van Belle, S Halimi.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15289742     DOI： 10.1016/s1262-3636(04)72800-1

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN： 1262-3636            Impact factor:   6.041


× No keyword cloud information.
  10 in total

1.  Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients.

Authors:  Daniele Bosone; Roberto Fogari; Matteo Cotta Ramusino; Natascia Ghiotto; Elena Guaschino; Annalisa Zoppi; Angela D'Angelo; Alfredo Costa
Journal:  Heart Vessels       Date:  2016-10-06       Impact factor: 2.037

2.  Exercise electrocardiographic responses and serum cystatin C levels among metabolic syndrome patients without overt diabetes mellitus.

Authors:  Asli Tanindi; Hilal Olgun; Ayse Tuncel; Bulent Celik; Hatice Pasaoglu; Bulent Boyaci
Journal:  Vasc Health Risk Manag       Date:  2011-02-06

3.  Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening.

Authors:  Michel M Lièvre; Philippe Moulin; Charles Thivolet; Michel Rodier; Vincent Rigalleau; Alfred Penfornis; Alain Pradignac; Michel Ovize
Journal:  Trials       Date:  2011-01-26       Impact factor: 2.279

4.  Diabetes and cardiovascular disease.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2011-03       Impact factor: 19.112

5.  Cardiovascular risk prediction is improved by adding asymptomatic coronary status to routine risk assessment in type 2 diabetic patients.

Authors:  Emmanuel Cosson; Minh Tuan Nguyen; Bernard Chanu; Isabela Banu; Sabrina Chiheb; Cristina Balta; Karim Takbou; Paul Valensi
Journal:  Diabetes Care       Date:  2011-07-20       Impact factor: 19.112

6.  Five-year outcomes in high-risk participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study: a post hoc analysis.

Authors:  Shanti Bansal; Frans J Th Wackers; Silvio E Inzucchi; Deborah A Chyun; Janice A Davey; Lawrence H Staib; Lawrence H Young
Journal:  Diabetes Care       Date:  2010-10-07       Impact factor: 19.112

7.  The Degree of Diabetic Retinopathy in Patients with Type 2 Diabetes Correlates with the Presence and Severity of Coronary Heart Disease.

Authors:  Taewoong Um; Dong Hoon Lee; Joon-Won Kang; Eun Young Kim; Young Hee Yoon
Journal:  J Korean Med Sci       Date:  2016-06-03       Impact factor: 2.153

8.  Screening of silent myocardial ischemia in type 2 diabetic patients: a randomized trial comparing isotopic and echocardiographic stress tests.

Authors:  Sophie Jacqueminet; Olivier Barthélémy; Claude Le Feuvre
Journal:  Diabetes Care       Date:  2010-06       Impact factor: 19.112

9.  Prognostic significance of the renal resistive index in the primary prevention of type II diabetes.

Authors:  Pascal Delsart; Anne Vambergue; Sandro Ninni; François Machuron; Bénédicte Lelievre; Guillaume Ledieu; Pierre Fontaine; Emilie Merlen; Marie Frimat; François Glowacki; David Montaigne; Claire Mounier-Vehier
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-31       Impact factor: 3.738

10.  Flow-mediated-paradoxical vasoconstriction is independently associated with asymptomatic myocardial ischemia and coronary artery disease in type 2 diabetic patients.

Authors:  Minh Tuan Nguyen; Isabelle Pham; Paul Valensi; Hélène Rousseau; Eric Vicaut; Christelle Laguillier-Morizot; Alain Nitenberg; Emmanuel Cosson
Journal:  Cardiovasc Diabetol       Date:  2014-01-15       Impact factor: 9.951
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.